文献速递生殖医学

钙离子载体人工卵母细胞激活改善不同病因不孕夫妇生殖结局的回顾性队列研究

Artificial oocyte activation to improve reproductive outcomes in couples with various causes of infertility: a retrospective cohort study.
PubMed 文献 · Reprod Biomed Online · 2020-01-09

该回顾性队列研究纳入2016至2018年间796对接受ICSI的夫妇,比较同一患者既往周期与ICSI后钙离子载体A23187激活周期的结局。结果显示,除原发性卵巢功能不全(POI)患者的活产率外,各组的着床率、β-HCG阳性率、临床妊娠率和活产率均显著改善;男性因素、不明原因及两者合并者的囊胚形成率和优质囊胚率显著提高,多囊卵巢综合征(PCOS)患者优质囊胚率提高,OAT、PCOS和不明原因不孕者的流产率显著降低。POI患者的受精率、胚胎发育和活产率无显著差异。

要点

  • 钙离子载体激活可改善多数不孕夫妇的着床、妊娠和活产结局。
  • OAT、不明原因不孕及合并因素者囊胚形成率和优质囊胚率显著提高。
  • POI患者受精率、胚胎发育和活产率未见显著改善。

核心结论

  • 人工卵母细胞激活可『挽救』部分有失败史的不孕夫妇的不良生殖结局。

研究设计与样本

  • 回顾性队列研究,纳入796对夫妇,共1261个ICSI周期和796个ICSI-AOA周期,同一患者既往周期为对照。

主要发现

  • 除POI患者活产率外,各组着床率、β-HCG阳性率、临床妊娠率和活产率均较既往周期显著改善(P < 0.05至P < 0.001)。
  • OAT、不明原因不孕及两者合并者囊胚形成率(均P < 0.001)和优质囊胚率(P < 0.05至P < 0.001)显著提高。
  • PCOS患者优质囊胚率提高(P = 0.0453)。
  • OAT、PCOS和不明原因不孕者流产率显著降低(P < 0.05至P < 0.001)。
  • POI患者两组间受精率、胚胎发育或活产率无显著差异。

关键数值与推荐

  • 所有 metaphase II 卵母细胞在ICSI后立即暴露于5 μmol/l离子载体15分钟。
  • 胚胎体外培养至囊胚阶段,于第5天移植或冷冻保存供下一周期移植。

临床怎么用

  • 对于有失败史的OAT、不明原因不孕、PCOS等特定类型不孕夫妇,可考虑ICSI后钙离子载体人工卵母细胞激活以改善结局。
  • POI患者可能无法从该激活方案中获益,需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does calcium ionophore treatment of oocytes improve fertilization rate, embryo development and outcomes in specific groups of infertile couples? DESIGN: This retrospective cohort study involved 796 couples undergoing oocyte activation with calcium ionophore (A23187) after intracytoplasmic sperm injection (ICSI) between 2016 and 2018. All metaphase II oocytes were exposed to 5 μmol/l ionophore for 15 min immediately after ICSI, cultured in vitro to the blastocyst stage, and transferred to the uteri of recipients on day 5 or cryopreserved for transfer in the next cycle. The previous cycles of the same patients formed the control group. RESULTS: Among 1261 ICSI cycles and 796 ICSI-artificial oocyte activation (ICSI-AOA) cycles, implantation, positive beta-HCG, clinical pregnancy and live birth rates were significantly (P < 0.05 to P < 0.001) improved for all groups, compared with previous cycles, except live birth rate in women with primary ovarian insufficiency (POI). Compared with previous cycles, rates of blastulation (all P < 0.001) and high-quality blastocysts (P < 0.05 to P < 0.001) were increased significantly for couples with male factor (oligoasthenoteratozoospermia [OAT]), unexplained infertility and couples with both factors in the ICSI-AOA cycles. High-quality blastocyst rate was increased in couples with polycystic ovary syndrome (PCOS) (P = 0.0453). Miscarriage rates were decreased significantly (P < 0.05 to P < 0.001) in couples with OAT, PCOS and unexplained infertility in the treatment cycles. No significant differences were found for fertilization rate, embryo development or live birth rate in patients with POI between both groups. CONCLUSIONS: Artificial oocyte activation was able to 'rescue' the poor reproductive outcomes in certain types of infertile couples with history of failure to achieve pregnancy.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Lv M, Zhang D, He X, et al. Artificial oocyte activation to improve reproductive outcomes in couples with various causes of infertility: a retrospective cohort study. Reprod Biomed Online. 2020. PMID: 32201115. doi:10.1016/j.rbmo.2020.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。